OBCK.F Ottobock SE & Co. KGaA
- Market cap
- EUR 2.53B
- P/E
- 19.7x
- P/B
- 7.52x
- ROE
- 34.3%
- Dividend yield
- 0.60%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is OBCK.F undervalued?
Graham numberOBCK.F trades 156.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ottobock SE & Co. KGaA fundamental analysis
No fundamental analysis for Ottobock SE & Co. KGaA yet.
Ottobock SE & Co. KGaA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and…
Full company profileOttobock SE & Co. KGaA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ottobock SE & Co. KGaA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2025 | 2026 Anlz |
|---|---|---|
| Income Statement | ||
| Revenue | 1.68B | 1.71B |
| Gross Profit | 887M | 897M |
| Operating Income | 233M | 232M |
| EBITDA | 381M | 403M |
| Net Income | 90.2M | 136M |
| EPS | 1.41 | 2.12 |
| Balance Sheet | ||
| Total Assets | 2.05B | 2.26B |
| Total Liabilities | 1.65B | 1.85B |
| Shareholders' Equity | 390M | 396M |
| Cash & Short-term Investments | 90.4M | 93.6M |
| Cash Flow | ||
| Operating Cash Flow | 333M | 236M |
| Capital Expenditure | 109M | 94.6M |
| Free Cash Flow | 225M | 141M |
| Ratios | ||
| ROE | 23.1% | 34.3% |
| ROA | 4.4% | 6.0% |
| Net Profit Margin | 5.4% | 7.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ottobock SE & Co. KGaA dividends
- Dividend yield
- 0.60%
- Forward dividend
- 0.97 EUR
- Payout ratio
- 16.7%
- Ex-dividend date
- May 20, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 15.1M | 0.24 | 16.7% |
| 2024 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ottobock SE & Co. KGaA
- Insiders 82.44%
- Institutions 11.58%
- Public & others 5.98%
- Shares outstanding 64.0M
- Free float 9.04M
Ottobock SE & Co. KGaA company profile
- Company name
- Ottobock SE & Co. KGaA
- Ticker
- OBCK.F
- ISIN
- DE000BCK2223
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 9,406
- Fiscal year end
- December
- Address
- Max-Näder-Straße 15, Duderstadt, Germany, 37115
- Phone
- 49 5527 848 0
- Website
- corporate.ottobock.com
About Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophisticated microprocessor-controlled; prosthetic knee joints and feet; arm and hand prostheses; and myoelectrical prostheses activities, as well as socket technologies, including liners, intelligent adaptors, and cosmetic components. It also provides fitting solutions for neurological indications; microprocessor-controlled orthotics, such as the C-Brace; and electrical muscle-activating stimulators, including exopulse suit and conventional orthotics; planning and equipping of patient care clinics; solutions for back, shoulder, neck, and wrist; customized orthopedic treatment and rehabilitation solutions; manual and power wheel chair; and standing aids and cushions, as well as care for amputees, including peripheral artery disease, traumatic limb loss, cancer, infections, congenital limb deficiencies, etc; and neurological etiologies, including stroke, multiple sclerosis, cerebral palsy/spinal cord injury, etc. In addition, the company leases out products, including wheelchairs and microprocessor-controlled knee joints. Ottobock SE & Co. was formerly known as Otto Bock HealthCare GmbH and changed its name to Ottobock SE & Co. KGaA in April 2018. The company was founded in 1919 and is based in Duderstadt, Germany. Ottobock SE & Co. KGaA operates as a subsidiary of Näder Upside 2 Vermögensverwaltungs GmbH.
Ottobock SE & Co. KGaA management
10- Mr. Oliver JakobiCEO, Chief Sales Officer & Member of Management Board · born 1968
- Prof. Hans Georg NaderChairman of Management Board · born 1961
- Dr. Joachim KreuzburgDeputy Chairman of the Management Board · born 1965
- Dr. Arne KreitzCFO & Member of the Management Board · born 1979
- Mr. Arne JornCOO, CTO & Member of Management Board · born 1968
- Mr. Martin BohmChief Experience Officer & Member of Management Board · born 1978
- Prof. Michael F. Kaschke Ph.D.Member of Management Board · born 1957
- Ms. Eva van PeltMember of Management Board · born 1965
- Dr. Katarzyna Mazur-Hofsaess M.D., Ph.D.Member of Management Board · born 1963
- Mr. Heiko ReinhardChief Information Officer